Deferring PCI Based on IVUS Assessment: On Par With FFR or FLAVOUR of the Week?

Affiliations

¹ Interventional Cardiology, Division of Cardiology, Department of Medicine, London Health Sciences Centre, Western University, ON, Canada (M.W.M., R.B.).
² Interventional Cardiology, Division of Cardiology, Department of Medicine, University of North Carolina, Chapel Hill (M.A.C.).

Editorial

Max W Maffey et al. Circ Cardiovasc Interv. 2023 Dec.

. 2023 Dec;16(12):e013649.

doi: 10.1161/CIRCINTERVENTIONS.123.013649. Epub 2023 Nov 29.

¹ Interventional Cardiology, Division of Cardiology, Department of Medicine, London Health Sciences Centre, Western University, ON, Canada (M.W.M., R.B.).
² Interventional Cardiology, Division of Cardiology, Department of Medicine, University of North Carolina, Chapel Hill (M.A.C.).

No abstract available

Keywords: Editorials; cardiologists; constriction, pathologic; humans; percutaneous coronary intervention.

Conflict of interest statement

Disclosures None.

Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision.
Lee JM, Kim H, Hong D, Hwang D, Zhang J, Hu X, Jiang J, Nam CW, Doh JH, Lee BK, Kim W, Huang J, Jiang F, Zhou H, Chen P, Tang L, Jiang W, Chen X, He W, Kang J, Ahn SG, Yoon MH, Kim U, Ki YJ, Shin ES, Choi KH, Park TK, Yang JH, Song YB, Choi SH, Gwon HC, Koo BK, Kim HS, Tahk SJ, Wang J, Hahn JY; FLAVOUR Investigators. Lee JM, et al. Circ Cardiovasc Interv. 2023 Dec;16(12):e013308. doi: 10.1161/CIRCINTERVENTIONS.123.013308. Epub 2023 Nov 29. Circ Cardiovasc Interv. 2023. PMID: 38018840